Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Northwest Missouri State University Opens Center for Innovation and Entrepreneurship
Northwest Missouri State University opened its new 46,000-sf science building in Maryville, Mo., in September of 2009. The $24 million Center for Innovation and Entrepreneurship houses $3 million in advanced laboratory instrumentation. Comprised of two wings, the mixed-use facility accommodates instructional space as well as industry tenants. Construction began on the project, which will support Northwest's nanoscience degree program, in 2005.
Bradshaw Medical Builds Kenosha Headquarters
Bradshaw Medical will break ground in September of 2009 on a new 60,000-sf headquarters in Kenosha, Wisc. Completion is expected in June of 2010. Bradshaw Medical is a manufacturer of orthopedic and spinal surgical instruments.
Brock University Breaks Ground on Niagara Health and Bioscience Research Complex
Brock University broke ground in September of 2009 on the $111 million Niagara Health and Bioscience Research Complex in St. Catherines, Ontario. The 169,000-sf project will house Canada's only research-dedicated CL3 biocontainment facility. Designed by architectsAlliance in association with Payette, the complex is being built by EllisDon with Crossey Engineering as electrical and mechanical consultant, MHPM as project manager, and Halsall Associates as LEED consultant.
United Therapeutics Opens Pharmaceutical Manufacturing Facility
United Therapeutics opened its $80 million pharmaceutical manufacturing facility in Research Triangle Park, N.C., in late summer of 2009. The 203,000-sf project was designed by O'Neal and provides solid dosage and sterile filling manufacturing facilities. The LEED-certified facility includes a data center, an auditorium, R&D and QA/QC labs, offices, warehouse space, and a fully integrated formulation pilot plant.
Beijing Vigoo Biological Constructs Vaccine Research Center
Beijing Vigoo Biological Co. is building the New Vaccine National Engineering Research Center in the Beijing Economic-Technological Developement Area. The 22,749-sm project will cost RMB 200 million to build and is slated for completion in December of 2010. Construction began in late June of 2009. Supporting vaccine research and development for H1N1 influenza, hepatitis, and measles, the facility will include five pilot-scale production lines, laboratories, and support. Beijing Vigoo Biological Co.